PKD1 and metastatic malignant neoplasm in the lymph nodes: Additionally, PKD1 was also found to be downregulated in non-small cell lung cancer patients with venous invasion or lymph node metastasis and loss of PKD1 enhanced the malignant potential of the tumor cells, possibly by negative regulation of mTORC1–S6K1 signaling [62].